Checking liver damage in people with type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This study looks at how well a simple blood test (called FIB-4) can measure liver damage (fibrosis) in people with type 2 diabetes. You may join to help find out if this test can help detect liver problems early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with type 2 diabetes.
- You are between the ages of 35 and 65.
- You have regular check-ups for diabetes every 3 months.
- You are not already being seen at a liver clinic for liver disease.
- You do not have active cancer, a blood disorder that causes low platelets, or are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who have both type 2 diabetes and fatty liver disease to see how these conditions affect heart health over time. By participating, you'll help researchers learn more about lowering your risk of heart problems.
This study looks at how the liver uses energy (mitochondria) in people with type 2 diabetes and fatty liver disease. By understanding this, researchers may find better ways to treat liver problems.
This study looks at how certain blood tests (liver biomarkers) change in people with higher risk for liver disease. It may help doctors understand who is developing liver problems earlier and what patterns in blood tests matter most.
This study checks if a simple score (FIB-4) can help find early liver cancer in people with type 2 diabetes. It aims to see if regular monitoring could help catch cancer sooner.
This study is for people with type 2 diabetes who may have early liver damage (fatty liver) but haven't yet developed severe scarring. It tests a simple screening program to find advanced liver fibrosis early, so it can be treated sooner.
This trial uses a blood test (FIB-4) to find liver scarring (fibrosis) in people who haven't been tested before. It aims to catch advanced liver disease early, which can help you get treatment sooner.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.